MENU
+Compare
ABBV
Stock ticker: NYSE
AS OF
Apr 3 closing price
Price
$201.64
Change
-$3.55 (-1.73%)
Capitalization
322.43B

ABBV ABBVIE Forecast, Technical & Fundamental Analysis

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta)... Show more

ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ABBV with price predictions
Apr 02, 2025

ABBV in +3.35% Uptrend, rising for three consecutive days on March 31, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ABBV advanced for three days, in of 365 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 53 cases where ABBV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

ABBV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 368 cases where ABBV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ABBV moved out of overbought territory on March 11, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 49 similar instances where the indicator moved out of overbought territory. In of the 49 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on March 21, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ABBV as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ABBV turned negative on March 13, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABBV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ABBV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ABBV's P/B Ratio (30.864) is very high in comparison to the industry average of (5.632). P/E Ratio (66.456) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (0.499) is also within normal values, averaging (3.004). Dividend Yield (0.033) settles around the average of (0.161) among similar stocks. P/S Ratio (5.900) is also within normal values, averaging (3.643).

View a ticker or compare two or three
ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ABBV is expected to report earnings to rise 16.20% to $2.51 per share on April 25

ABBVIE ABBV Stock Earnings Reports
Q1'25
Est.
$2.51
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.08
Q2'24
Missed
by $0.05
Q1'24
Beat
by $0.04
The last earnings report on January 31 showed earnings per share of $2.16, beating the estimate of $2.06. With 7.59M shares outstanding, the current market capitalization sits at 322.43B.
A.I.Advisor
published Dividends

ABBV paid dividends on February 14, 2025

ABBVIE ABBV Stock Dividends
А dividend of $1.64 per share was paid with a record date of February 14, 2025, and an ex-dividend date of January 15, 2025. Read more...
A.I. Advisor
published General Information

General Information

a research-based pharmaceutical company

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1 North Waukegan Road
Phone
+1 847 932-7900
Employees
50000
Web
http://www.abbvieinvestor.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
D56.250.02
+0.04%
Dominion Energy
OGN14.45-0.27
-1.83%
Organon & Co
TCBK37.13-2.61
-6.57%
TriCo Bancshares
BCAL12.97-1.22
-8.60%
California BanCorp
GENK4.75-0.72
-13.16%
GEN Restaurant Group

ABBV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABBV has been loosely correlated with PFE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ABBV jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABBV
1D Price
Change %
ABBV100%
-1.73%
PFE - ABBV
54%
Loosely correlated
-1.66%
JNJ - ABBV
40%
Loosely correlated
+2.87%
AMGN - ABBV
35%
Loosely correlated
+1.36%
NVS - ABBV
33%
Poorly correlated
+1.35%
BMY - ABBV
32%
Poorly correlated
-2.99%
More